Related Experiment Video
Updated: Dec 3, 2025

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
14.6K
Active case-finding policy development, implementation and scale-up in high-burden countries: A mixed-methods survey
Olivia Biermann1, Phuong Bich Tran1, Kerri Viney1,2
1Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Plos One
|October 28, 2020
Summary
National TB Programme managers advocate for scaling up active case-finding (ACF) but face resource constraints. Strategies to overcome these challenges, including local evidence generation and stakeholder engagement, are crucial for tuberculosis control.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Health Policy and Management
Background:
- The World Health Organization (WHO) emphasizes active case-finding (ACF) for early tuberculosis (TB) detection, particularly in 30 high-burden countries responsible for nearly 90% of global cases.
- Effective ACF strategies are critical for reducing TB transmission and mortality.
Purpose of the Study:
- To assess the perspectives of National TB Programme (NTP) managers regarding ACF policy development, implementation, and scale-up in high-burden countries.
- To review national TB strategic plans for alignment with ACF objectives.
Main Methods:
- A mixed-methods approach combining a cross-sectional survey of NTP managers with a review of national TB strategic plans.
- Quantitative and qualitative data from surveys and plan reviews were analyzed in parallel.
Main Results:
- 77% of NTP managers participated in the survey; 73% of national TB strategic plans were reviewed.
- NTP managers identified district and regional managers as key stakeholders for ACF policy and implementation.
- While NTP managers agreed on the need for ACF scale-up and recognized potential long-term cost savings, most reported current financial and human resource shortages. Strategies to address these constraints were identified.
Conclusions:
- NTP managers support scaling up ACF but highlight significant resource limitations.
- Implementing strategies like generating local evidence and involving sub-national managers is essential for successful ACF scale-up.
- Addressing resource constraints through operational research and advocacy is vital for advancing TB control efforts.
Related Concept Videos
Pulmonary Tuberculosis V
349
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
349
Pulmonary Tuberculosis IV
309
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
309
Pulmonary Tuberculosis I
574
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
574
Pulmonary Tuberculosis II
1.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.0K
Pulmonary Tuberculosis III
669
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
669
International Nursing Organizations II
1.2K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.2K

